Gen-Probe to acquire Tepnel Life Sciences - MarketLine Financial Deals

Gen-Probe to acquire Tepnel Life Sciences

Gen-Probe to acquire Tepnel Life Sciences - MarketLine Financial Deals
Gen-Probe to acquire Tepnel Life Sciences
Published Jan 30, 2009
3 pages — Published Jan 30, 2009
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Gen-Probe Incorporated, a US-based developer of nucleic acid diagnostics, has agreed to acquire all the outstanding and to-be-issued shares of Tepnel Life Sciences, PLC, a UK-based molecular diagnostics company.

  
Source:
Document ID
MA01415_090202
Country
Country
Ticker
GPRO=US
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Gen-Probe to acquire Tepnel Life Sciences" Jan 30, 2009. Alacra Store. Feb 19, 2017. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Gen-Probe-to-acquire-Tepnel-Life-Sciences-2052-1347>
  
APA:
MarketLine Financial Deals. (2009). Gen-Probe to acquire Tepnel Life Sciences Jan 30, 2009. New York, NY: Alacra Store. Retrieved Feb 19, 2017 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Gen-Probe-to-acquire-Tepnel-Life-Sciences-2052-1347>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.